Schedule 13G ownership disclosure

CIDARA THERAPEUTICS INC

Security class unavailable · CUSIP: 171757107

Event date: 2017-10-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
11.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-322869
Form type
SC 13G/A
Filer
BB BIOTECH AG
CIK
CIK 924223
Filed
Oct 27, 2017
Reporting period
Oct 24, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub